Spironolactone Tablet
Product Images NDC 71335-2217

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 71335-2217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

Structure (Spironolactone 01)
Chemical structure of Spironolactone. The diagram depicts the molecular arrangement of atoms and bonds characteristic of the spironolactone compound.*
FDA Label Image

Figure 1 (Spironolactone 02)

Figure 1 (Spironolactone 02)
A Kaplan-Meier survival curve comparing probability over months between Spironolactone (n=822) and placebo (n=841) groups. The graph shows a decreasing trend in probability, with Spironolactone consistently showing higher survival probability than placebo over approximately 42 months, with a statistically significant log-rank p-value < 0.001.*
FDA Label Image

Figure 2 (Spironolactone 03)

Figure 2 (Spironolactone 03)
A forest plot showing hazard ratios (HR) with 95% confidence intervals (CI) for various subgroups in a study comparing spironolactone and placebo. Subgroups include age, sex, race, LVEF percentage, heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The horizontal axis represents the HR, with markers indicating the effect direction for spironolactone versus placebo.*
FDA Label Image

Label (Lbl713352217)

Label (Lbl713352217)
Label for Spironolactone Tablets USP, 25 mg, oral tablets, containing 1000 tablets. The label includes warnings to keep medication out of reach of children, storage instructions between 20° to 25°C, and dispensing information. It shows the NDC 71335-2217-1, with Bryant Ranch Prepack as the relabeler and Frontida BioPharm, Inc. as the manufacturer.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.